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ABSTRACT 
Cells in the mammalian hearing organ, the cochlea, develop a specialized patterning 
and cellular architecture necessary for hearing function. Cytoskeletal components, such 
as actin and microtubules, maintain the material and mechanical properties of these 
cells. One way to understand cell material properties is to measure the response of the 
cytoskeleton to mechanical stress. Mechanical stress to sensory hair cells and non-
sensory supporting cells in the cochlear epithelium, the organ of Corti, can lead to 
hearing loss, and currently these cells cannot recover from cytoskeletal damage. 
Quantification of the mechanical properties of these cells as they develop is lacking. By 
understanding cytoskeletal development, it may be possible to repair damaged cells to 
restore hearing function. 
 
Using Atomic Force Microscopy, we measured cell surface mechanical properties in 
cochlear tissue culture during development. We calculated and compared the Young's 
modulus of sensory outer hair cells (OHCs) and non-sensory supporting pillar cells 
(PCs) at discrete time points between embryonic day 16 (E16) and postnatal day 5 (P5). 
We find the first distinctions between OHC and PC Young's modulus in the late 
embryonic period, after E16. By P5, PCs have developed a network of acetylated 
microtubules that occupy the majority of PC cytoplasm, which may in part explain the 
higher Young’s modulus and increased stiffness relative to OHCs, which are primarily 
composed of actin filaments at the lumenal surface.  
 
To understand the growth factors regulating cochlear cellular development after E16, 
we antagonized both the Fibroblast growth factor (Fgf) and thyroid hormone (TH) 
signaling pathways. Using an in vivo mouse model, we find that loss of Fgfr3 leads to a 
decrease in the Young's modulus of both OHCs and PCs, which suggest that the 
disruptions to tissue architecture may contribute to the hearing loss in these animals. To 
disrupt TH levels in the cochlea, timed-pregnant female mice were treated with 
methimazole to induce a hypothyroid state in utero. We find that hypothyroid cochleae 
have a delay in down regulation of Fgfr3 in OHCs and disruptions to OHC and PC 
morphology. Interestingly, OHCs and PCs are stiffer in hypothyroid relative to control 
conditions. By examining both the transcriptional profile and the Fgf-signaling cascade, 
we find that the aberrant cellular stiffening results in part from persistent activation of 
Fgf-receptors and the actin depolymerizing factor cofilin.  
 
Finally, we wanted to examine the morphology and mechanics of OHCs and PCs 
before they are fully differentiated. Using immunohistochemistry and confocal 
microscopy, we find that overlap of prosensory specific markers, including Islet1, 
Sox2, and Jagged1, may help to refine the population of prosensory cells that will give 
rise to the organ of Corti. Defining this region may permit quantification of prosensory 
cell surface mechanical properties in the un-differentiated sensory epithelium. 
Together, these data suggest that growth factors impact the developing OHC and PC 
cytoskeleton, which dictates cell surface mechanical properties during development. By 
understanding the material properties of these cell types, future research may consider 
manipulation of growth factor signaling pathways to repair the organ of Corti in order 
to restore hearing function.  
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1 INTRODUCTION 
Hearing loss is partly due to the inability to repair or regenerate damaged inner ear 
sensory hair cells or non-sensory supporting cells. By understanding morphogenesis in 
the inner ear sensory epithelium, the cochlea, we may be able to apply the mechanisms 
of development to therapeutic interventions for hearing loss. One obstacle to 
manipulating developmental processes is the lack of understanding of the contribution 
of cytoskeletal components that resist cellular deformations, during development or 
through the process of hearing. If we can better understand the mechanics of 
development, then we can potentially manipulate those mechanisms to facilitate repair 
or regeneration.  
 
1.1 CELL MECHANICS AND MORPHOGENESIS 
 
Figure 1. Tissue Morphogenesis. Examples of cell-based events in tissue morphogenesis, including 
contraction, rotation, invagination, and intercalation. These changes in cell shape are induced by apically 
driven changes in cytoskeletal components, such as actin (red), myosin (green), microtubules (blue) and 
cell-cell junctions (yellow). Figure adapted from Martin and Gelbart, 2010; Gillies and Cabernard, 2011; 
Gorfinkiel and Blanchard, 2011; Levayer and Lecuit, 2012. 
 
Cell shape changes and movements are part of the growth and maturation of 
tissues throughout the body. Epithelial morphogenesis includes the re-distribution of 
forces during cell shape changes. These tissue movements (Figure 1) can be described at 
the cellular level as contraction, invagination, intercalation, and rotation (Levayer and 
Lecuit, 2012). Furthermore, changes in cell shape often manifest changes in the 
material properties of the cell, such as the stiffness or elasticity. Stiffness is a material’s 
resistance to deformation by applied force. This is an extensive property of a given 
structure dependent on both the material shape and constituent components. Elasticity 
is the material property by which a structure can return to a resting shape after 
deformation, which is defined as stress or strain. Cells also have a fluid component, and 
the resistance to deformation of a fluid is termed viscosity. It is for this reason that cells 
are often referred to as viscoelastic, since cell contents can also behave like a viscous 
fluid. Quantitative descriptions of cell mechanical properties may lend insight into 
these cell shape changes.  
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Figure 2. Atomic Force Microscopy (AFM) to be applied to cell morphogenesis.  (A) Schematic of 
AFM stiffness measurement with cantilever in contact with the sample surface (blue). Position of 
cantilever is monitored by tracking a laser reflected off the surface of the cantilever and onto a 
photodiode detector. The force (F) applied by the cantilever is a function of the cantilever spring constant 
(k) and distance (d) traveled by the cantilever. The photodiode can detect the displacement (δ), which 
includes both the distance and the indentation of the sample (z). (B) Tip dimensions for gold-coated 
silicon nitride cantilever (Bruker Nanoprobes) used in AFM experiments. µm, micrometer. (C) Sample 
force-distance curve (blue). The force-distance curve contains three parts, a non-contact region (green 
line), and a contact point (orange arrow). The contact region of the curve is analyzed by applying non-
linear least-squared fit (red) to estimate Young’s modulus (Ym). The force-distance curve shown has a 
goodness of fit (R2) value equal to 0.9989. nm, nanometer; nN, nano-Newton. 
 
One measurement of cell mechanical properties is the Young’s modulus (Ym). 
This elastic modulus is an intensive property independent of changes in shape. A lower 
Ym is a desirable property of a material when higher flexibility is necessary. One way 
to measure Ym is to adapt optical microscopy to include applications of controlled 
force. The atomic force microscope (AFM) places a microscopic cantilever probe 
(Figure 2) in contact with a cell or tissue sample in order to apply a wide range of 
forces (10 pN to N) over several scales in length (50 nm to 10 µm). Movements of a 
laser reflected from the cantilever probe onto a detector provide a minimally invasive 
technique that does not require fixation (Figure 2). The high resolution for both 
imaging and force measurements requires a sharp AFM probe. One constraint of the 
surface area of the tip shape is a greater exertion of stress (σ = Force/Area), which can 
be corrected through optimization of the cantilever’s shape for the desired experiment. 
In summary, application of AFM allows quantification of the changes in cell mechanics 
and may directly influence tissue development. 
 
To extract Ym from AFM measurements, the data must be fit to the applicable 
model (Figure 2). The force on a rigid cone indenting an elastic half-space was 
modeled by Sneddon and Love (Love, 1939; Sneddon, 1965). These, and subsequent 
specifications thereafter assume that for a cantilever of known stiffness, the amount of 
deformation is dependent on the elastic modulus of the material in contact (see 
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Appendix I). This model also assumes that the sample is linearly elastic, 
homogeneous, and isotropic, and that indentation depth is small relative to the height of 
the sample. Further solutions account for special deviations considering AFM probe 
geometry, (Bilodeau, 1992; Briscoe et al., 1994). More recently, additional 
considerations to optimize the use of AFM to estimate the Ym of biological samples 
(Dimitriadis et al., 2002) has been followed by an increasing interest in understanding 
the mechanical properties of stem cells (Yim et al., 2010) or scaffolds thought to guide 
directed cell behaviors (Sundararaghavan et al., 2011), both of which may provide 
quantitative data that help to describe the developmental time course of cells and 
tissues.  
 
The shape changes observed during epithelial morphogenesis are driven largely by 
the apically concentrated cytoskeletal components, actin and non-muscle myosin (NM). 
The motor activity of NM-II increases fluidity, which is the opposite of viscosity, in 
poorly cross-linked actin (Koenderink et al., 2009), while NM-II motor activity 
increases stiffness in highly cross-linked actin (Humphrey et al., 2002). This suggests 
that decreasing NM-II activity could have different effects in neighboring cells based 
on the extent of cross-linking. Also, turnover in actin filaments has been shown to 
increase fluidity (Lieleg et al., 2008). In vivo, mice with mutations in NM-II-A or NM-
II-B have heart defects and hydrocephalous, respectively, and are embryonically lethal 
(Tullio et al., 1997; Conti et al., 2004). In contrast, NM-II-C mice survive to adulthood 
and are viable (Ma et al., 2010). These data suggest that the cytoskeleton, cross-linked 
by myosin motors, may be contributing to the shape changes in cells that are necessary 
for embryonic development. 
 
1.2 DEVELOPMENT OF THE MOUSE INNER EAR 
The mouse inner ear is an excellent model system by which to further understand 
the impact of cell mechanics on cell structure and tissue function. The structure of the 
inner ear (Slepecky, 1996) can be sub-divided functionally into the auditory and 
vestibular epithelia. The auditory sensory epithelium, the cochlea, is responsible for 
hearing function and can be further divided into three domains (Figure 3). The neural 
domain, which includes spiral ganglion neurons and surrounding non-neuronal 
mesenchymal and glial cells, sends auditory stimuli to central projections for higher 
auditory processing. The sensory domain, the organ of Corti, converts sound waves into 
electrochemical signals that are transmitted to spiral ganglion neurons. Finally, the non-
sensory domain contains supporting cells that maintain ionic homeostasis (Kikuchi et 
al., 2000) and structural integrity of the cochlea. These structures were initially 
characterized based primarily on cell shape, morphology, and position within this 
auditory epithelium. However, it is still unclear how these domains are specified and 
organized within the cochlea. 
 
 
Figure 3. Development of the organ of Corti (OC). (A) The developing cochlear duct at embryonic day 
14 (E14) can be sub-divided into three domains, the neural domain (ND), prosensory domain (PS), and 
non-sensory domain (NS). This apical region of the prosensory domain will give rise to the OC, and is 
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shown here to express prosensory marker Sox2 (red) and cell cycle regulator p27Kip1 (green). The ND 
also expresses Sox2 and is immunopositive for neurotrophin receptor p75 (p75ntr). By postnatal day 0 
(P0), both inner hair cells (IHCs) and outer hair cells (OHCs) have Phalloidin (blue) labeled actin 
stereocilia bundles, and are arranged in stereotyped rows that are separated by non-sensory supporting 
cells that are shown here to express either Jagged1 (red) in the OC or Numb (green) in Kölliker’s organ 
(KO). (B) Prosensory specification is the first stage in the differentiation of the OC. Prosensory cells can 
be specified into either hair cells, which express hair cell markers Atoh1, and later Myosin6, or support 
cells, which can express one or several markers of differentiation, including Sox2, Prox1, Jagged1, p75ntr, 
or Numb. Scale bar 50 µm. 
 
The organ of Corti (Figure 4) contains two types of mechanosensory hair cells that 
are distributed into a single row of inner hair cells (IHCs) and three rows of outer hair 
cells (OHCs). Additionally, there are 7 types of non-sensory supporting cells. 
Supporting pillar cells (PCs), between IHCs and OHCs, form the fluid-filled tunnel of 
Corti during postnatal stages of mammalian development. Deiters’ cells interdigitate 
between the three rows of OHCs and also form fluid-filled spaces of Nuel below the 
OHC lumenal surface. Similarly, inner phalangeal cells are interdigitating the IHC row. 
Claudius’, Hensen’s, and Boettcher’s cells are located lateral to the OHCs, and form the 
lateral edge of the organ of Corti. The medial edge of the organ of Corti contains non-
sensory cells of the greater epithelial ridge, also known as Kölliker’s organ, which will 
develop into the cells surrounding the fluid-filled inner sulcus. The apical surface of the 
organ of Corti, herein referred to as the lumenal surface, is covered by the tectorial 
membrane, while the basolateral surface is bounded by the basilar membrane. The 
specialized cellular structure and patterning of this epithelium begins during embryonic 
stages of development and continues through the postnatal period until the onset of 
hearing at postnatal day 12 (P12) in the mouse (Alford and Ruben, 1963). 
 
 
Figure 4. Distribution of cytoskeletal proteins in the organ of Corti (OC). (A) Views of the postnatal 
day 0 (P0) OC in cross-section (left) and whole-mount (right) shows one row of IHCs and three rows of 
OHCs with interdigitating non-sensory supporting cells, IPh, inner phalangeal cell; IP, inner pillar cell; 
OP, outer pillar cell; Deiters’ cell, DC; HC, Hensen’s cell; CC, Claudius’ cell; BC, Boettcher’s cell. 
Microtubule isotypes and Myosin II localization are shown in both views. (B) Views of the P12 OC in 
cross-section (left) shows fluid filled spaces including the tunnel of Corti (ToC) and spaces of Nuel 
(asterisk) as well as the differential distribution of γ- and β-Actin isoforms. Whole-mount view (right) 
shows differential distribution of microtubule isotypes in hair cells and support cells in the OC. Adapted 
from Jensen-Smith et al., 2003. 
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Research on cochlear development has taken advantage of genetic ablations in the 
mouse to relate transcription factors to the specification (Figure 3) and formation of 
cochlea-specific hair cells and supporting cells (Kelley et al., 2009). The cochlear duct 
extends from an invagination of the hindbrain beginning between embryonic day 10 
(E10) and E12. By E12, LIM-homeodomain transcription factor Islet1 is expressed 
within the cochlear duct in cells that will give rise to cells in the prosensory and 
proneural domains (Radde-Gallwitz et al., 2004). In addition, the sex-determining-
region-Y box transcription factor Sox2 is expressed in prosensory cells (Kiernan et al., 
2005), proneural cells (Puligilla et al., 2010) and newly differentiated supporting cells 
in an antagonistic interaction with Atoh1 (Dabdoub et al., 2008). The basic helix-loop-
helix transcription factor Atoh1 (Ben-Arie et al., 1996) is expressed in prosensory cells 
and the time when sensory cell specification begins at E13. A majority of these cells 
will develop into hair cells (Driver et al., in press), and Atoh1 is essential for hair cell 
formation (Bermingham et al., 1999). Interestingly, inner-PCs maintain some plasticity 
during postnatal development, as ectopic expression of Atoh1 in these cells induces 
expression of hair cell markers (Liu et al., 2012). It is not yet clear why PCs lose the 
ability to transdifferentiate into hair cells, or how this ability might be extended. 
Finally, the prospero-homeobox transcription factor, Prox1, is expressed in the 
developing sensory epithelium in embryonic development and down-regulated in 
OHCs before birth at E18. Expression is maintained only in a subset of non-sensory 
supporting cells, PCs and Deiters’ cells, only through the first two postnatal weeks 
(Bermingham-McDonogh et al., 2006). Together, these data help to clarify the 
mechanisms of cell specification in the sensory domain of the cochlea. However, 
specification of the prosensory cells that will eventually give rise to hair cells and 
supporting cells is still not well understood. 
 
It has been suggested that the specification of prosensory cells as either hair cells 
or supporting cells is the result of lateral inhibition (Gierer and Meinhardt, 1974) 
organized by mosaicism in expression of ligands and receptors in the Notch signaling 
pathway (Lewis, 1996). Previous reports have shown that developing hair cells express 
Notch ligands Delta-like 1 and Jagged2. Genetic deletion of either of these genes or 
their receptor, Notch1, leads to an increase in the number of hair cells as a result of the 
loss of lateral inhibition (Lanford et al., 1999; Kiernan et al., 2006). Later, during late 
embryonic stages of development, Notch ligand Jagged1 is expressed in the cochlea in 
supporting cells immediately adjacent to hair cells and extends into Kölliker’s organ at 
E17.5 (Morrison et al., 1999). In addition, neurotrophin receptor p75 (p75ntr), is also 
expressed in the cochlea from E14.5 through the early postnatal period (Gestwa et al., 
1999). Expression data also show this receptor to be localized to a subset of supporting 
cells, PCs, and show that down-regulation of this receptor occurs in the first postnatal 
week of development. Interestingly, p75ntr is dispensable for cochlear development 
(Brors et al., 2008), but deletion of p75ntr leads to early onset hearing loss (Sato et al., 
2006). From these data, it is clear that a better understanding of supporting cell 
differentiation may increase the potential for therapeutic alterations to support cell 
plasticity through postnatal stages of development. 
 
In addition to transcriptional specifications, the concomitant regulation of cell 
number is also an important developmental process in the embryonic organ of Corti. 
Cell cycle exit begins in apical regions of the organ of Corti at E13 (Ruben, 1967). 
However, the regulators of cell cycle progression that have been studied extensively in 
isolated mitotic cells (Mitchison and Salmon, 2001) are still not fully characterized in 
the cochlear sensory epithelium. Targeted deletion of cell cycle regulator 
Retinoblastoma protein leads to cell-cycle re-entry and an over-proliferation of cell 
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within the cochlear sensory epithelium (Sage et al., 2005). Similarly, deletion of cyclin-
dependent kinase inhibitor p27Kip1, also results in prolonged cellular proliferation, an 
increase in hair cells and support cells, and deafness (Chen and Segil, 1999) and is 
largely responsible for cell-cycle control in the organ of Corti (Lee et al., 2006). As 
both of these cell-cycle regulators maintain their expression in supporting cells longer 
than hair cells, it may be possible to regulate cell-cycle controls to proliferate hair cells 
in damaged cochleae.  
 
While hair cell and supporting cell specification occurs in embryonic stages of 
mouse development, these cells also undergo extended and distinct stages of structural 
differentiation throughout postnatal development (Figure 4). The OHCs develop actin-
rich mechanosensory hair bundles, stereocilia, which are stabilized within an actin-
dense meshwork called the cuticular plate. The cuticular plate of OHCs contains both 
β- and γ-actin, and mutations disrupting either isoform lead to early onset age-related 
hearing loss (Perrin et al., 2010), suggesting that these isoforms each function to 
maintain OHC structure, but are not necessary for OHC structural development. 
Furthermore, the development of the cuticular plate is thought to be constrained by the 
organization of the stereocilia (Etournay et al., 2010). Mutations in γ-actin have also 
been linked to human deafness loci DFNA20/26 (Zhu et al., 2003; Morín et al., 2009). 
Myosins, which regulate cytoskeletal motility by cross-linking actin filaments, also 
impact OHC shape and structural integrity. Several myosin motor proteins have been 
shown to localize to the cochlea and impact hair cell structure (Coling et al., 1997; 
Richardson et al., 1997; Belyantseva et al., 2005). For example, Myosin 6 localizes to 
the cuticular plate of IHCs and OHCs (Avraham et al., 1995) and loss of this protein 
leads to degeneration of the mouse sensory epithelium by P18 (Avraham et al., 1995). 
Along the lateral wall of the OHCs, an actin-based spectrin-cross-linked cortical lattice 
(Holley and Ashmore, 1990) attaches to the plasma membrane by as yet unidentified 
pillars (Forge, 1991; Fridberger et al., 2009). Measurements of the distance between 
filaments in this lattice suggest that the cortical actin primarily contributes to the 
circumferential stiffness and shape of the OHC (Holley et al., 1992). Stiffness 
measurements in isolated adult OHCs suggest that the plasma membrane also 
contributes to the mechanical properties of the cortical actin network (Tolomeo et al., 
1997).  However, the actin-dense cuticular plate stiffness has not yet been measured. 
 
In contrast to OHCs, mature PCs are composed primarily of 15-protofilament 
microtubules. Polymerization of microtubules is thought to proceed during early 
postnatal development from the lumenal surface, down the longitudinal axis of the cell 
towards the basolateral surface in contact with the basilar membrane (Hallworth et al., 
2000). There are several types of post-translational modifications of microtubules, 
including acetylation, tyrosination, detyrosination, and polyglutamylation. It is known 
that microtubules with low turnover and high stability have more modifications (Wloga 
and Gaertig, 2010), but it is unclear whether these modifications are a consequence or a 
cause of microtubule dynamics. PC microtubules are first acetylated and then 
detyrosinated during postnatal development (Tannenbaum and Slepecky, 1997). These 
post-translational modifications suggest that PCs contain stable microtubules relative to 
OHCs, which are primarily composed of tyrosinated microtubules (Slepecky et al., 
1995). PCs also contain a network of actin filaments localized to the apical surface and 
footplate contacting the basilar membrane. Relative to OHCs, PCs contain more γ-actin 
and less β-actin at the apical surface, and a differential distribution of actin isoforms is 
present between apical and basal PCs (Furness et al., 2005). Actin and microtubules are 
further stabilized within the cytoplasm by the presence of tropomyosin (Slepecky and 
Chamberlain, 1987) and myosin II (Yamamoto et al., 2009). Together, these data 
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suggest that many of the cytoskeletal components described here (Fig. 1), may have a 
functional role dictating cell structure and cell mechanical properties during 
development. 
 
The structural development and patterning of the cochlear sensory epithelium are 
essential for hearing function. In the cochlea, sounds are spatially arranged by 
frequency domains. Even complex sounds are mapped by frequency onto the cochlea 
and these sounds vibrate discrete regions of the basilar membrane. Each area of the 
basilar membrane shows maximal response to one frequency. The base of the basilar 
membrane responds maximally to high frequencies and the apex responds to low 
frequencies. This graded response along the longitudinal direction of the basilar 
membrane is referred to as a tonotopic gradient (von Békésy, 1956). In order to achieve 
this resolution of different frequencies along different locations, the properties of the 
basilar membrane also show some gradients in morphology. The basilar membrane is 
thin and narrow at the base, and wide and thick at the apex (Kimura, 1975; Dallos, 
1996). However, measurements of point stiffness made in the radial direction, from 
medial PCs laterally to the OHC rows, on the basilar membrane also show a gradient in 
response (Olson and Mountain, 1994; Emadi et al., 2004). This suggests the observed 
difference in stiffness at different radial locations of the basilar membrane may have a 
cellular basis. It is clear that these sensory and supporting cells are required for hearing 
function. At a cellular level, hearing loss is observed in animal models that exhibit a 
misdirected development of patterning in the epithelium, or a collapse of fluid-filled 
spaces, such as the inner sulcus (Rüsch et al., 2001), spaces of Nuel (Merchant et al., 
2004) or tunnel of Corti (Colvin et al., 1996; Hayashi et al., 2007; Puligilla et al., 2007). 
It is thought that the PCs that form the tunnel of Corti provide structural support to the 
organ of Corti, and stiffness measurements on isolated adult PCs suggest that 
microtubules contribute most to the cell mechanical properties (Tolomeo and Holley, 
1997). Therefore, it is of great interest to measure the mechanical properties of these 
cells within the organ of Corti, and modulate either hair cell and supporting cell specific 
markers, or cytoskeletal components, to determine the impact of cell development on 
hearing function.  
 
1.3 FIBROBLAST GROWTH FACTORS IN COCHLEAR DEVELOPMENT 
The growth, proliferation and differentiation of the cells required for the 
formation of the organ of Corti is mediated through growth factor signaling. One 
important subset of growth factor signaling is the Fibroblast growth factor (Fgf) 
signaling pathway. Secreted Fgfs bind to a subset of tyrosine kinase Fgf-receptors 
(Fgfrs). This sub-family contains Fgf ligands that can bind to Fgf-receptors (Fgfrs), 
which signal intracellularly by activating tyrosine kinases. The Fgf-family contains 23 
ligands and 7 different Fgfr proteins, which vary in ligand binding affinity (Olsen et al., 
2004), dimerization (Mangasarian et al., 1997) and affinity for heparin sulfate 
proteoglycans (Ibrahimi et al., 2004). The latter are necessary for receptor binding to an 
Fgf ligand (Shimokawa et al., 2011). Fgfrs can be further sub-divided by the 
mechanism of action, as some can signal over short, paracrine, or long, endocrine-like 
distances (Ornitz, 2000).  
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Figure 5. Downstream activation of Fibroblast growth factor (Fgf) signaling pathway.   As shown, 
Fgf ligands bind in the presence of HSPG, heparin sulfate proteoglycan, to Fgf-receptors that can affect 
several downstream cascades including MAPK, PLC-γ, PI3K, and STAT to control growth, proliferation, 
and differentiation of the cell. Transcriptional targets have been divided into those that feedback on Fgf-
signaling (1), and transcription factors (2). P, phosphate; Shc, Src homology 2 domain-containing protein; 
Src, non-receptor tyrosine kinases; Grb2, growth factor receptor bound protein-2; Frs2, Fibroblast growth 
factor receptor substrate 2; SOS, guanine nucleotide exchange factor Son of Sevenless; Crk, adaptor 
molecule binding to tyrosine-phosphorylated proteins; Ras, Rat sarcoma small GTPase protein; Rac, 
small Rho GTPase family member; PAK, serine/threonine-protein kinase; LIMK, Lim-domain-kinase; 
SSH, slingshot; CIN, chronophin, cofilin-activating phosphatase; Erk1/2, extracellular signal-regulated 
kinase; p38 MAPK, mitogen-activated kinase; T.K., Tyrosine Kinase. Adapted from Mason, 2007 and 
Bernstein and Bamburg, 2010. 
Receptor dimerization leads to activation of four key pathways (Figure 5): MAPK, 
PI3K, STAT, and PLC-γ (Itoh and Ornitz, 2011). Fgf-induced MAPK activation occurs 
in the developing zebrafish telencephalon (Shinya et al., 2001), embryonic chick 
(Stavridis et al., 2007), and vertebrate limb bud (Gros et al., 2010). These data suggest 
that MAPK activation is essential for the growth and differentiation of target tissues, 
including the cochlea. In adult stages, the cochlea upregulates MAPK signaling in 
response to noise trauma (Jamesdaniel et al., 2011), and has been observed in the 
presence of hair cell death (Matsui et al., 2004; Lahne and Gale, 2008). The role of 
MAPK signaling in cochlear development has not yet been fully described. However, 
studies in the avian auditory epithelium, which maintains the potential to regenerate, 
have shown that MAPK inhibition decreases supporting cell proliferation during 
regeneration (Witte et al., 2001; Bell and Oberholtzer, 2010). The specificity of Fgf-
signaling through different downstream cascades is thought to be regulated by the 
presence and binding of adaptors and co-factors such as Fgfr-specific substrates, Frs 
molecules (Hoch and Soriano, 2006) and growth-factor receptor bound protein Grb2 
(Lin et al., 2012). Like many growth factor signaling cascades, Fgf-induced MAPK 
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signaling has been shown to be associated with regulatory feedback loops. In particular, 
activation of transcription of MKP3 leads to production of a MAPK-phosphatase that 
negatively regulates Fgf-signaling (Li et al., 2007). 
 
Fgf ligands can bind multiple Fgf receptors (Olsen et al., 2004). Many of these 
ligands are transcribed from genes that either map to deafness loci or are associated 
with congenital deafness (Fgfs 1, 3, 6, 8, 13, 14, 20, 22). One-third of these 23 ligands 
have very low or no expression in the cochlea (Fgfs 2, 4, 6, 11, 15, 17, 22, 23). All four 
genes that encode Fgfr proteins are expressed in the developing cochlear duct (Pickles, 
2001; Hayashi et al., 2010). Fgfr4 mRNA expression localizes this receptor to the 
mesenchyme surrounding the sensory epithelium. Fgfr1 is expressed on the medial side 
of the cochlear duct in presumptive OHCs and the greater epithelial ridge cells as early 
as E13.5. This receptor has been implicated in patterning of the sensory epithelium 
during embryonic development (Pirvola et al., 2002). Fgfr2 is expressed on the lateral 
side of the cochlear duct in non-sensory supporting cells of the spiral ligament and in 
Hensen’s and Claudius’ cells. This receptor is thought to have a paracrine mode of 
action in the developing cochlear duct (Privola et al., 2000). Furthermore, this gene has 
been mapped to a known deafness locus, DFNB57, and is associated with several types 
of craniosynostosis (Orvidas et al., 1999; Desai et al., 2010). 
 
Fgfr3 is not expressed in early embryonic development, but is present in the late 
embryonic period (E16.5-E18) broadly within the sensory epithelium in both hair cells 
and supporting cells. However, by postnatal day 0, Fgfr3 mRNA expression is down-
regulated in OHCs and persists in non-sensory pillar and Deiters’ cells (Mueller et al., 
2002; Hayashi et al., 2010). Mutations in Fgfr3 lead to achondroplasia and deafness in 
both humans (Doherty et al., 2007) and mice (Colvin et al., 1996; Hayashi et al., 2007; 
Puligilla et al., 2007). One hallmark of this mutation in the cochlea is the malformation 
of the pillar cells that mature to form the Tunnel of Corti. This suggests that Fgf-
signaling plays a role in pillar cell structural development. However, it remains to be 
seen how Fgf-signaling exerts control over cytoskeletal formation.  
 
1.4 THYROID HORMONE SIGNALING  
Another important growth factor for cochlear development is thyroid hormone. 
Thyroid hormones are tyrosine-based hormones produced in the thyroid gland. 
Circulating thyroid hormone, thyroxine (T4), which takes advantage of a long half-life 
(Brown-Grant, 1967), travels through the blood stream to target tissues (Figure 6). This 
inactive T4 is converted into the active form, triiodothyronine (T3), by iodothyronine 
deiodinase selenoenzymes through a de-iodination reaction. If there is a deficiency of 
iodine, then this mineral could be the limiting reagent in the production of active T3. 
There are three known de-iodinase enzymes (Galton, 2005). Deiodinase 1 (D1) and D2 
can convert T4 into T3. However, there are data to suggest that these two enzymes are 
not functionally redundant, as D1 is dispensable for mammalian development 
(Schneider et al., 2005) while inactivation of D2 leads to decreased regulation of 
thermogenesis in brown adipose tissue (de Jesus et al., 2001). Overall, these D2-/- mice 
have a phenotype consistent with pituitary resistance to T4 (Schneider et al., 2001). D3 
is known to convert the high affinity T3 ligand, and T4, into a functionally inactive 
thyroid hormone, rT3 (Galton, 2005), which suggests that this enzyme negatively 
regulates thyroid hormone signaling in most target tissues. In the cochlea, D2 is present 
in the cochlear duct within the first postnatal week of development and localizes to 
non-sensory domains that include spiral ligament and osseous spiral lamina (Ng et al., 
2009). D2-/- mice show a developmental delay in cochlear development and 40dB 
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auditory brainstem response threshold shift (Ng et al., 2004). In contrast to D2, D3 is 
expressed in late embryonic stages of development, and localizes to non-sensory 
domains including stria vascularis, spiral ganglia, and tympanic border cells beneath 
the basilar membrane (Ng et al., 2009). D3-/- mice show acceleration of cochlear 
differentiation and 70 dB sound pressure level hearing loss (Ng et al., 2009). 
 
 
Figure 6. Thyroid hormone action.  Schematic representation of some mechanisms by which thyroid 
hormones (T3 and T4) regulate gene transcription. (1) Circulating T3/T4 enter target tissues via thyroid 
hormone transporters, including Lat1, Mct8&10, and Oatp1c1. (2) Inside the cytoplasm, T3 levels are 
tightly controlled by the activity of deiodinase selenoenzymes (D2/D3). (3) Inside the nucleus, T3 bound 
to thyroid hormone receptors (TRs), which can heterodimerize to Retinoid X Receptor (RXR), can 
activate or repress gene transcription through binding with co-activators or nuclear-co-repressors (N-Co-
Rs). (4) Alternatively, T4 can bind to Integrin receptors, which then activate transcription factors (TF) 
capable of regulating target gene transcription in the nucleus. Figure adapted from Weitzel, 2008, and 
Horn and Heuer, 2010. 
 
More recently, research efforts have focused on the mechanisms used by target 
tissues to carry circulating T4 into target cells. These thyroid hormone transporters are 
well-characterized in several target tissues including the monocarboxylate transporters 
(Mcts) in the central nervous system (Schweizer and Köhrle, 2012). However, thyroid 
hormone transport in the cochlea is not well understood. First characterization of 
thyroid hormone transporters noticed much overlap between transporters Lat1, Mct8, 
Mct10, Oatp1c1, and deiodinase enzymes (Sharlin et al., 2011), particularly in the 
greater epithelial ridge, tympanic border cells, and spiral ligament. During development 
in utero, the availability of thyroid hormones is based solely on maternal production 
(Patel et al., 2011) and thyroid hormone transport across the placenta is sensitive to 
iodine uptake (Burns et al., 2011), as well as thyroid hormone binding proteins 
(McKinnon et al., 2005; Mortimer et al., 2012) and transporters (Loubière et al., 2010). 
Together, these data suggest multiple layers of potential regulatory mechanisms on 
thyroid hormone metabolism during development.  
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Two thyroid hormone receptor (TR) genes, Thra and Thrb, are post-
transcriptionally modified to encode the 4 nuclear receptors—Thra encodes TRα1 and 
TRα2, while Thrb encodes TRβ1 and TRβ2. In the cochlea, expression of Thrb is 
evident as early as E12.5 (Bradley et al., 1994). By P1, Thrb expression is down-
regulated in the sensory epithelium and refined to a subset of cells within the greater 
epithelial ridge (Ng et al., 2009).  In contrast, Thra expression is evident by P0 in the 
spiral ganglia of the cochlear and vestibular organs. These expression patterns are 
particularly interesting given the late onset of expression of deiodinase enzymes (Ng et 
al., 2009) and suggest a potential ligand-independent action by TRs. Loss of TRβ1 
impairs auditory function by disrupting potassium currents in IHCs (Forrest et al., 
1996), showing this receptor to be necessary for hearing function. In contrast, loss of 
TRα1 leads to abnormally slower heart rate and decreased body temperature in mice 
(Wikström et al., 1998). Mutations causing deletion of all known thyroid hormone 
receptors delay differentiation of the organ of Corti and result in malformations of the 
tectorial membrane, inner sulcus, and tunnel of Corti (Rüsch et al., 2001), which 
suggests that there are some receptor-independent or compensatory mechanisms of 
thyroid hormone signaling on cochlear structural development.  
 
Thyroid hormone action (Figure 6) through TRs can result from homodimerization 
(Piedrafita et al., 1995) or heterodimerization with Retinoid X Receptors (RXRs) (Yu et 
al., 1991; Kliewer et al., 1992). It was shown that heterodimerization stabilizes TRs on 
DNA (Hallenbeck et al, 1992) but it is still not clear the extent to which receptor 
binding is a transient or sustained phenomenon. In either case, the mechanism for this 
stability was further examined with X-ray crystal structures of the ligand-binding 
domain, which suggest that this region mediates the probability of TRs to interact as 
homodimers or heterodimers with RXRs (Ribeiro et al., 2001). TRs can regulate target 
gene transcription through binding to thyroid hormone response elements (TREs) 
(Desvergne, 1994) in promoter or enhancer regions. There is also evidence of non-
classical activation by TREs within introns (Sap et al., 1990). The TRE consensus 
sequence, 5'-AGGTCA-3' (Umesono et al., 1991) usually appears as tandem repeats, 
which can be direct repeats, inverted, or everted. Direct repeats are occupied by 
homodimers (Umesono et al., 1991). An inverted repeat, or palindromic sequence, has 
been characterized in the promoter region of growth hormone (Glass et al., 1987) and 
the everted repeat has been shown to have the potential for ligand-independent 
activation (Sjöberg and Vennström , 1995). It was first shown that the spacing of these 
and other consensus sequences was the primary factor that directed binding of 
homodimers or heterodimers to DNA (Forman et al., 1992), but it is also possible that 
the presence of ligand and the aforementioned dimerization can impact TR binding to 
DNA. Finally, a synthetic receptor was engineered to show that it is possible for TRs to 
bind monomer TREs (Katz and Koenig, 1994), but a thyroid hormone target gene 
containing a monomeric site in the promoter region has yet to be identified.  
 
Thyroid hormone receptors can act as either activators or repressors of target gene 
transcription. This additional layer of regulation on TRs has been attributed to the 
specificity of thyroid hormone associated proteins (Koenig et al., 1998). These proteins 
are sub-divided into transcriptional co-activators or co-repressors. Co-activators of 
nuclear receptors, including TRs, recognize a signature amino acid motif, LXXLL 
(Heery et al., 1997), where L is leucine and X is any other amino acid. However, some 
co-activators, such as the protein Trip230 can vary in binding as a result of 
conformational changes in the TR ligand-binding domain (Chang et al., 1997). Co-
repressors also play an important role for TRs bound to DNA independent of ligand. 
These proteins bind a hinge region between the ligand and DNA binding domains of 
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TRs (Hörlein et al., 1995) and include the family of nuclear-co-repressors N-CoRs, 
(Hörlein et al., 1995) and silencing mediator of retinoid and thyroid receptors, SMRTs 
(Chen and Evans, 1995). The mechanism of T3-dependent repression of gene 
transcription remains poorly understood relative to the mechanisms of co-activators, in 
part as a result of a lack of similar co-repressor activity in the model yeast S. cerevisiae 
(Olson et al., 1998). Taken together these data support a further need for understanding 
the mechanisms of thyroid hormone and TR action, and the complex interactions 
between multiple signaling networks. 
 
There is a growing body of evidence to support the hypothesis that there may be 
cross-talk between thyroid hormone and Fgf-signaling pathways. For example, 
overproduction of thyroid hormone will induce negative feedback mechanisms (Kaplan 
and Yaskoski, 1982) to prevent an overload of T3 in the central nervous system. 
However, treatment with Fgf ligand also induces a concentration dependent increase in 
D3 activity (Esfandiari et al., 1992). This regulation can vary by tissue type. Fgf also 
increases expression of D2 protein in cultured astrocytes (Lennon et al., 1994) that was 
sustained over 24 hours in vitro. It is unclear whether these pathways have a mutual 
dependency on target genes that induce feedback mechanisms directly, or if Fgf-
signaling indirectly regulates thyroid hormone status. In contrast to the regulation on 
thyroid hormone by Fgf, it is clear that thyroid hormones have a direct impact on the 
Fgf-signaling pathway. First, T3 stimulates expression of all Fgfr’s (Barnard et al., 
2005). Second, a thyroid hormone response element is present in the promoter region of 
Fgfr1 (O'Shea et al., 2007). Finally, thyroid hormone regulates heparin sulfate 
expression in the developing growth plate. Images from tibial growth plates of the 
mouse show increased proteoglycan expression when low levels of T3 are present 
(Bassett et al., 2006). Together, these data suggest multiple stages of regulation by 
thyroid hormones on Fgf-signaling, and motivate a further understanding of thyroid 
hormone action specifically in the cochlea. 
 
1.5 SPECIFIC AIMS 
The development of the cochlea impacts auditory function. Cochlear hair cell and 
support cell development is regulated by the timing of differentiation and cytoskeletal 
formation. However, the impact of the developing cytoskeleton on cell mechanics has 
not been quantified. The first aim of this thesis is to measure the surface mechanical 
properties of developing OHCs and PCs, in the intact sensory epithelium using AFM, 
and characterize the impact of cytoskeletal structure on developing cell mechanics. 
Since cytoskeletal formation is often the result of growth factor stimulation, the second 
aim of this thesis is to assess the impact of Fgf and thyroid hormone signaling upstream 
of cytoskeletal growth and cell mechanical properties. Finally, the specification of 
prosensory cells within the organ of Corti may lead to early detection of different 
mechanical properties of sensory hair cells and non-sensory supporting cells. Therefore, 
the third aim of this thesis seeks to characterize the convergence of multiple markers of 
differentiation in order to define the prosensory region in the organ of Corti before hair 
cell and support cell specification.  
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2 MATERIALS AND METHODS 
 
2.1 COCHLEAR EXPLANT CULTURES 
Cochleae from Institute for Cancer Research (ICR) mice (Charles River 
Laboratories, Frederick, Maryland, USA) were cultured at specific stages between E16 
and P5 as previously described (Montcouquiol and Kelley, 2003). Briefly, the temporal 
bone was harvested from a hemi-sectioned mouse skull, and the cochlear sensory 
epithelium was exposed by removing the bony capsule, stria, Reissner’s membrane, 
and tectorial membrane. All dissections were performed in 1X Hanks Buffered Salt 
Solution (Invitrogen, Frederick, Maryland, USA) containing 1mM (4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid) (HEPES) (Invitrogen) and brought to pH 7.4 with 10N 
NaOH (Fluka, Sigma-Aldrich, Reston, Virginia, USA). Cochleae were plated on 3% 
Matrigel (BD Biosciences, Bedford, Massachusetts, USA) -coated No.1 glass 
coverslips (Corning, New York, USA) and cultured in 200 µL Dulbecco's Modified 
Eagle Medium, DMEM (Invitrogen), containing 0.1 mg/mL Ciproflaxin HCl 
(Mediatech Inc., Corning, New York, USA) and 1X N2 supplement (Invitrogen). 
Cochlear explant cultures varied in thickness from 30-50 µm. Fgfr3-deficient mice 
were kindly provided by Dr. David Ornitz (Washington University in St. Louis, 
Missouri, USA). These and Atoh1lacZ/+ reporter mice were bred on a C57 black 6 
background strain (Charles River Laboratories, Frederick, Maryland, USA) to generate 
Atoh1lacZ/+  or Fgfr3-/- animals. Fgfr3-/- mice are viable but have a 60 dB sound pressure 
level hearing loss compared to wild-type littermates (Colvin et al., 1996). Additionally, 
cochleae from Deiodinase 2 knockout mice (D2-/-), which have a phenotype consistent 
with hypothyroidism in the cochlea (Ng et al., 2004), and littermate controls were 
kindly provided by the laboratory of Dr. Douglas Forrest (NIDDK, Bethesda, 
Maryland, USA). All animal care and procedures were approved by the Animal Care 
and Use Committee at NIH and complied with the NIH guidelines for the care and use 
of animals.  
 
2.1.1 Pharmacology 
To decrease thyroid hormone signaling in vivo, animals were treated with 0.02% 
methimazole (Sigma) and 10% sucrose (MP Biomedicals, Solon, Ohio, USA,) in 
drinking water and low iodine feed (TD.120363, Harlan Laboratories, Madison, 
Wisconsin, USA) administered ad libitum. To increase thyroid hormone signaling in 
vitro, explants were treated with 5 μM triiodothyronine (Sigma-Aldrich) or 5 μM 
reverse triiodothyronine (Sigma-Aldrich), an inactive form of thyroid hormone, as a 
control, in DMSO. To disrupt the cytoskeleton in vitro, tissue cultures were treated 
after 12-17 hours in vitro for 30 minutes with one of the following: 1 µM Latrunculin A 
(Sigma-Aldrich) in DMSO, 5 µM Jasplakinolide (Sigma-Aldrich) in DMSO, 10 µM 
Blebbistatin (Sigma-Aldrich) in DMSO, 1 µM Taxol (Sigma-Aldrich) in DMSO, 5 µM 
Nocodazole (Sigma-Aldrich) in 1X PBS, or vehicle control added to Leibovitz’s media 
(GIBCO, Invitrogen). To affect the Fgf signaling pathway, tissue explants were treated 
immediately after plating with either 10 µM SU5402 (EMD Chemicals, Millipore, 
Billeria, Massachusetts, USA) in DMSO, or 1 µM Fgf2 (R&D Systems, Minneapolis, 
Minnesota, USA) in 1X PBS with 0.1% DMSO and 1 µg/ml heparin sulfate alone or in 
combination with one of the following: 5 µM Y27632 (Sigma-Aldrich) in sterile water, 
10 µM SP600125 (Sigma-Aldrich) in DMSO, or 1 µM U0126 (Sigma-Aldrich) in 
DMSO. 
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2.2 OUTER HAIR CELL (OHC) VOLTAGE-DEPENDENT CAPACITANCE 
Organ of Corti explants were dissected at postnatal day P4 and cultured in 
DMEM supplemented with 25 mM HEPES, 7% fetal bovine serum (Invitrogen) and 10 
µg/ml ampicillin (Calbiochem, Millipore) at 37°C and 5% CO2 as described previously 
(Russell et al., 1986; Russell and Richardson, 1987; Stepanyan et al., 2006). The organ 
of Corti explants were cultured 2 to 6 days in vitro. Experiments were performed in L-
15 cell culture media (Invitrogen) containing the following inorganic salts (in mM): 
NaCl (137), KCl (5.4), CaCl2 (1.26), MgCl2 (1.0), Na2HPO4 (1.0), KH2PO4 (0.44), 
MgSO4 (0.81). Hair cells were observed with an inverted microscope (Eclipse TE2000-
U, Nikon) using a 100X 1.3 NA oil-immersion objective with differential interference 
contrast. To access the basolateral plasma membrane of OHCs, the outermost cells 
were removed by gentle suction with a ~5 µm micropipette. Pipettes for whole-cell 
patch-clamp recordings were filled with intracellular solution containing (in mM): CsCl 
(140), MgCl2 (2.5), Na2ATP (2.5), EGTA (1.0), HEPES (5). Osmolarity and pH of the 
intrapipette solution were adjusted with D-glucose and CsOH to match corresponding 
values of the bath (325 mOsm, pH ~ 7.35). The pipette resistance was typically 2–4 
MOhm when measured in the bath. Patch clamp recordings were performed with a 
computer-controlled amplifier (MultiClamp 700B, Molecular Devices). Measurements 
of cell capacitance were performed using the “membrane test” feature of the pCLAMP 
9.2 acquisition software (Molecular Devices), which continuously delivered a test 
square wave of period of 4 msec to the cell through the patch-clamp amplifier. The 
errors of the capacitance measurement algorithm of pCLAMP were corrected offline to 
account for a non-ideal ratio of the access resistance to the membrane resistance as 
previously described (Frolenkov et al., 2000). To determine the voltage dependence of 
OHC capacitance, we applied triangular voltage ramps. Measurements of the cell 
capacitance during test ramps were corrected for the voltage drop along the access 
resistance of the pipette. Data were fit to the derivative of the Boltzmann function, 
 , where   ,  is the voltage-
independent (linear) capacitance,  is the electrical charge transferred across the 
plasma membrane upon transition of the cell from fully extended to fully contracted 
state,  is the potential at the peak of , z is the effective valence of a charge 
moving from the inner to the outer aspect of the plasma membrane, k is Boltzmann’s 
constant, T is absolute temperature (293 Kelvin), and e is the electron charge. To 
compare the data obtained from different cells, the voltage-dependent (non-linear) 
capacitance component was divided by the surface area of the plasma membrane with 
the formula  ; where  is the specific non-linear voltage-
dependent capacitance of the plasma membrane in µF/cm2 and  = 1 µF/cm2 is the 
specific capacitance of a lipid bilayer. 
 
2.3 ATOMIC FORCE MICROSCOPY (AFM) 
Experiments were performed using a commercially available Bioscope II and 
Bioscope Catalyst AFM (Bruker, Santa Barbara, California, USA) head mounted onto a 
Zeiss Axiovert 200 inverted microscope and controlled via a Nanoscope V controller 
(Bruker). Pyramidal shaped, gold-coated, silicon nitride cantilever probes with 0.03 
N/m spring constant (part MLCT, Bruker) were used for all measurements. The AFM 
system and microscope were mounted on a vibrationally isolated table with pneumatic 
support. To detect the position of the cantilever, a 3.9 mW laser with wavelength 850 
nm was focused with a lens, and reflected from a mirror onto the cantilever. At the 
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beginning of each experiment, the laser was aligned with the cantilever and photodiode 
detector. Cells were identified after being loaded with 500 nM Calcein AM vital dye 
(Invitrogen) in Leibovitz’s medium (Invitrogen) for 30 minutes and rinsed with fresh 
Leibovitz’s medium. Instrument control to move the sample surface in X and Y 
dimensions, to move the cantilever in the Z dimension, and data acquisition was 
performed with commercial Nanoscope software (Bruker). The position of the sample 
and the cantilever were detected with 10X (Plan Neofluar®, ∞ 0.17, NA 0.30, WD= 5.5 
mm, ZEISS) and 40X (Plan Neofluar®, ∞ 0.17, NA 0.75 WD= 0.71 mm, ZEISS) 
objectives. Contact mode AFM was applied to all samples in 300-500 µL of 
Leibovitz’s medium at 1.5 μm maximum indentation using 3 μm ramps at 1 Hz 
continuous force ramping to collect 3 force-distance curves for the center of each 
identified hair cell or supporting cell. For line-scan measurements, a 50 µm2 region of 
interest was selected and points over the lumenal surface of the second row of OHCs 
and PC rows were examined with 2 µm equal spacing. Because the base of IHCs is 
rotated in explant cultures, these measurements were excluded from the analysis. 
Relative force-distance curves were collected with ~300 nm trigger threshold using 3 
µm force ramping at 1 Hz for three cycles. Images of all samples were collected before, 
during, and at the conclusion of each experiment using a standard fluorescence lamp 
(X-CITE 120, Lumen Dynamics Group Inc., Mississauga, Ontario, Canada) and cooled 
charge-coupled device (Orca R2, Hamamatsu Photonics K.K., Japan) controlled by 
AFM acquisition software (Bruker). 
 
2.3.1 Data Analyses 
All force-distance curves were processed offline with custom analysis software in 
MATLAB (Mathworks, Natick, Massachusetts, USA) and fit to the Sneddon model 
(Sneddon, 1965) to measure Young’s modulus (Ym), which is a material property of 
the cellular resistance to deformation and was calculated with the formula F = 
(2/πtanα)(E/(1-ν2))δ2; where F is applied force, ν is Poisson’s ratio and assumed to be 
0.5, δ is cantilever indentation, and α is cantilever tip angle. Only force-distance curves 
with a goodness of fit (r2) greater than 0.98 were used. Average Ym (mean±s.e.m.) was 
calculated from the average of sample measurements of 10 cells within a given region 
of interest such as the base or the apex of the cochlea.  
 
2.3.2 Statistical Analyses 
To test for a normal distribution of the collected data, a Shapiro-Wilk test was 
performed using MATLAB (Mathworks) software and the formula 
, where is the order statistic,  is the sample 
mean, and  are the constants from the covariance matrix of expected values of the 
order statistic, if the data were from independent and identically distributed random 
values. To quantitatively describe different distributions in the data, a two-tailed 
Kolmolgorov-Smirnov distribution difference test was performed using MATLAB 
software and the formula  where  is the experimental 
cumulative distribution function,  is a standard normal cumulative distribution 
function, and  is the supremum, or least upper bound, of distances in the set of data. 
Means were compared using a custom Excel (Microsoft) spreadsheet and the formula 
for Welch’s T-test  (Welch, 1947), or the Student’s T-test  
where  is the sample mean,  is the sample standard deviation, is the pooled 
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standard deviation, and  is the sample size. The degrees of freedom for Welch’s T-
test were calculated with a custom Excel spreadsheet and the formula 
. The degrees of freedom for the Student’s T-test were calculated 
as . All p-values were corrected with the Bonferroni correction for multiple 
testing. 
 
2.4 POLYMERASE CHAIN REACTION (PCR) 
All genotypes were examined with PCR, which confirmed that the genetic 
deletion leads to a loss of both ligand binding and transmembrane domains of Fgfr3 
(Colvin et al., 1996). Genomic DNA was extracted from animal tail-clips using Easy-
DNATM Kit (Invitrogen). Template DNA was added to illustra© PuRe Taq Ready-to-
go© PCR beads (GE Healthcare), and 50 рg custom primers (Invitrogen), and brought 
to a final volume of 25 µL with PCR grade water (Quality Biological, Gaithersburg, 
Maryland, USA). 40 cycles of PCR amplification were performed with the following 
cycling conditions: 94C, 30 seconds; 56C, 30 seconds; 72C, 30 seconds. PCR 
products were examined with electrophoresis on pre-cast 4% agarose gels (Invitrogen) 
and compared to molecular weight standards. Primer sequences used were as follows:  
Fgfr3 WT, Forward 3’-AGGTATAGTTGACACCATCGGAGGG -5’;  
Fgfr3 MUT, Forward 3’- TGCTAAAGCGCATGCTGGAGACTGC-5’;  
Fgfr3 Common, Reverse 3’-GGGCTGGTTATTGGACTCGC -5’. 
 
2.4.1 Quantitative Polymerase Chain Reaction (QPCR)  
Cochleae were removed from the temporal bone, and the surrounding 
mesenchyme, scala vestibuli and scala tympani were removed. 6-8 cochleae were 
pooled and total RNA was isolated using RNAqueous (Ambion, Grand Island, New 
York, USA) reagents. Complementary DNA (cDNA) was synthesized from 500 ng 
total RNA for each condition using a Superscript III first strand synthesis kit 
(Invitrogen). Amplification was performed with SYBR Green (Applied Biosystems, 
Foster City, California, USA) and combined with RNAse-free water to a final reaction 
volume of 10 µL. For RT2 Profiler PCR Array of mouse cytoskeletal regulators 
(PAMM-088ZA, SABiosciences, Qiagen, Gaithersburg, Maryland, USA), cDNA was 
combined with RT2 SYBR Green ROX qPCR Mastermix (SABiosciences) and 
RNAse-free water to a final reaction volume of 25 µL. RT2 Profiler PCR Array  
experiments were repeated in triplicate for each condition. Amplification of all mRNA 
was performed on an ABI Prism 7000 (Applied Biosystems) with the following cycling 
conditions: 40 cycles of 95C for 15 seconds, and 60C for 1 minute. To calculate fold 
change, gene expression was normalized to glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) and statistical significance was confirmed with student’s T-test. Primer 
sequences used were as follows:  
Fgfr1, Forward, 3’-ATGGTTGACCGTTCTGGAAG-5’;  
Fgfr1, Reverse, 3’-AGAAAAGGGTACGCAGCAGA-5’;  
Fgfr3, Forward, 3’-GAGACTTGGCTGCCAGAAAC-5’;  
Fgfr3, Reverse, 3’-GGGCTCACATTTGTGGTCTT-5’,  
GAPDH, Forward, 3’-ATCCTGTAGGCCAGGTCATG-5’;  
GAPDH, Reverse, 3’-TATGCCCGAGGACAATAAGG-5’. Six cochleae per condition 
were pooled for RNA extraction and cDNA synthesis using an RT2 First Strand Kit 
(Qiagen). To express similarity among relative cytoskeletal regulator gene expression 
levels, a hierarchical clustering method was used (RT2 ProfilerTM Software, Qiagen). 
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This method applied the correlation coefficient as a similarity metric, as well as the 
absolute expression level and an average linkage method, to calculate the average 
distances between all pairs of genes. 
 
2.5 IN SITU HYBRIDIZATION 
Temporal bones were isolated and fixed in 4% paraformaldehyde (Electron 
Microscope Sciences) in 1X PBS (Invitrogen) and rinsed for 15 minutes in 1X PBS 
repeated three times. Six cochleae from each condition were examined at each time 
point. Samples were passed through a 5-30% sucrose gradient, and embedded in 
Optimal Cutting Temperature (Tissue-Tek, Electron Microscopy Sciences, Hatfield, 
Pennsylvania, USA) freezing compound. Samples were stored in air-tight containers at 
-80C before being cryosectioned at 12 μm thickness on a cryostat microtome 
(CM3050S, Leica). In situ hybridization was performed on 6 sections of each condition 
with probes specific to Fgfr1 (Gift from Thomas A. Reh) and Fgfr3 (Jacques et al., 
2007). 
 
2.5.1 In Situ Hybridization Probes.  
Plasmid templates were amplified in GC10 cells grown in Lennox L Base Broth 
(Invitrogen) containing 50 µg/mL Ampicillin antibiotic (Sigma-Aldrich) for 18-24 
hours. Plasmid isolation was performed with a commercially available Maxi Prep kit 
(Qiagen) and resuspended at approximately 5 µg/µL in buffer TE. Plasmid was 
linearized for five hours at 37C with 20 U/µL restriction enzyme (New England 
Biolabs, Ipswich, Massachusetts, USA) in 1X restriction buffer (New England 
Biolabs). Linearization was confirmed with electrophoresis on pre-cast 2% agarose gel 
(Invitrogen) and compared with molecular weight standards. This DNA template at 
approximately 1µg/µL was reverse transcribed for two hours at 37C to RNA 
hybridization probe using 20 U/µL RNA polymerase (Roche, Indianapolis, Indiana, 
USA), 40 U/µL RNAse inhibitor (Roche) and alkaline phosphatase-conjugated 
digoxigenin (DIG) RNA labeling nucleoside triphosphates (NTPs) at 1X. This RNA 
probe was concentrated using an ethanol precipitation containing LiCl.  
 
2.5.2 Pre-treatment and Hybridization. 
Sections mounted on slides that were stored at -80C before use were dried at 
room temperature before being fixed with 4% paraformaldehyde (Electron Microscopy 
Sciences) containing 0.2% gluteraldehyde (Electron Microscopy Sciences) in 1X PBS. 
Slides were rinsed in 1X PBS, bleached in 6% hydrogen peroxide (Fisher Scientific), 
washed in 0.1% PBS-Tween-20 (PBST), and permeabilized with 20 µg/mL Proteinase 
K for 2 minutes. This reaction was quenched with 2 mg/mL glycine in PBST for 10 
minutes. Finally, the slides were washed in PBST, fixed with 4% paraformaldehyde 
containing 0.2% gluteraldehyde in 1X PBS, and washed in PBST, before being sealed 
in Kapak (Minneapolis, Minnesota, USA) pouches containing 10 mL hybridization 
solution of 50% Formamide (Sigma), 50 µg/mL heparin sulfate, and 50 µg/mL Yeast 
RNA in 1% Sodium dodecyl sulfate (SDS) set to pH 5 with Sodium-Sodium Citrate 
(SSC) Buffer. Slides were pre-hybridized for 4-6 hours at 70C before RNA probe was 
added and hybridized overnight. 
 
2.5.3 Post-hybridization wash and Antibody Binding. 
The next day, slides containing specimens were removed from Kapak pouches and 
submerged in 70C pre-warmed Formamide containing 1% SDS with gentle agitation. 
Slides were submerged in 65C pre-warmed Formamide containing 2.5% 20X SSC 
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Buffer with gentle agitation. Slides were washed in 1X Tris-Buffered Saline-0.1%-
Tween-20 (TBST) containing Levimasole and blocked with 10% Chicken Serum 
(Invitrogen) for at least 2 hours at room temperature. Finally, slides were placed in 
Kapak pouches containing 10 mL of TBST containing Antidioxygenin AP at 1:5000 
dilution and incubated at 4C overnight on a rocking platform (VWR). 
 
2.5.4 Post-antibody-wash and Detection. 
Slides were removed from Kapak pouches and submerged in TBST. Slides were 
washed in alkaline phosphatase buffer before adding 0.05 g 5-Bromo-4-chloro-3-
indolyl-phosphate, NBT (Roche) in 70% dimethyl formamide (Sigma-Aldrich) and 
0.03 g BCIP (Roche) in RNAse-free water. This reaction solution was incubated with 
the specimens until the desired color intensity was reached. All slides treated with the 
same probe were treated with the same reaction solution for the same duration to 
compare relative intensities. This reaction was quenched with 1 mM EDTA (VWR 
Scientific, Reston, Virginia, USA) solution in PBST for 20 minutes at room 
temperature. Slides were mounted with Fluoromount-G (Southern Biotech, 
Birmingham, Alabama, USA) mounting solution beneath No. 1 Coverslips (Corning) 
adhered with commercially available nail polish. 
 
2.5.5 Image Acquisition and Processing 
Slides were examined at room temperature using a Nikon Eclipse 800 
fluorescence microscope (Melville, New York, USA) in differential interference 
contrast (DIC) imaging mode with 20X (Plan Apochromat, ∞ 0.17, NA 0.75, WD =1.0 
mm, Nikon) and 40X (Plan Apochromat, ∞ 0.14, NA 0.52, WD = 0.14 mm, Nikon) 
objectives. Images were acquired using a DXM1200 Camera (Nikon) and 
accompanying camera system software (Nikon). Images were cropped in Adobe 
Photoshop CS4 (Adobe). 
 
2.6 WESTERN BLOT 
Cochlear explants were freshly isolated before total protein extraction. Proteins 
were extracted from 8-10 cochleae in RIPA buffer containing complete mini protease 
inhibitor cocktail (Roche), complete phosphatase inhibitor cocktail (Roche), 1 mM 
Na3VO4, and 500 mM NaF. Protein was quantified using the Dc protein assay kit (Bio 
Rad) and Lowry method with ND-1000 Spectrophotometer (Nanodrop, Wilmington, 
Deleware, USA).  25 μg total protein per condition was loaded onto 4-12% SDS-PAGE 
gels (Invitrogen) run for 2 hours at 120 V, transferred to nitrocellulose membrane 
(Invitrogen), and run for 3 hours at 80 V at 4°C. Membranes were blocked in 0.05% 
TBST containing BLOTTO (Rockland, Gilbertsville, Pennsylvania, USA) containing 
1% Bovine Serum Albumin (Sigma). Primary antibodies were incubated in blocking 
solution at the following concentrations: p-Fgfr (1:500, Cell Signaling), p-LIMK 
(1:500, abcam), p-Cofilin (1:500, abcam) Fgfr (1:2500, Life Technologies, Frederick, 
Maryland, USA), LIMK (1:5000, abcam), Cofilin (1:5000, abcam), and β-Actin 
(1:5000, Sigma). Primary antibodies were conjugated to horseradish peroxidase anti-
rabbit or anti-mouse secondary antibody (1:5000, Amersham) and detected using ECL 
Detection Reagents (Amersham).  
 
2.6.1 Image Acquisition and Processing  
Membranes were visualized using Image Station 4000R (KODAK) and 
Carestream Molecular Imaging Software (New Haven, Connecticut, USA). Image 
analysis was performed with ImageJ (Rasband, 1997) using the Gel Analysis plug-in 
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method to calculate relative density. Relative density of phosphorylated protein signal 
was normalized to β-actin signal for the same tissue and under the same experimental 
conditions. Statistical significance was determined with Welch’s T-test (Welch, 1947). 
Images with the median relative density for each antibody in each condition were 
imported for image preparation by being cropped and resized in Adobe Photoshop CS4 
(Adobe). 
2.7 TRANSMISSION ELECTRON MICROSCOPY  
Cochleae from 3 animals at each time point for each condition were isolated and 
placed immediately in 0.1 M phosphate buffer (pH 7.4) containing 4% 
paraformaldehyde and 2% glutaraldehyde for 30 minutes at room temperature followed 
by 2 hours at 4C. The inner ears were then washed in phosphate buffer and cacodylate 
buffer, post-fixed with 1% osmium tetroxide, dehydrated through a graded alcohol 
series, and stained with 1% uranyl acetate in 50% ethanol. Samples were embedded in 
Poly/BED 812 resin (Polysciences Inc., Warrington, Pennsylvania, USA) as previously 
described (Petralia and Wenthold, 1992). Thin sections of about 75 nm were cut using a 
Leica Reichert ultramicrotome, stained with lead citrate, mounted on 200-Copper mesh 
grids (Electron Microscopy Sciences), and examined at room temperature using a 
JEOL transmission electron microscope (Akishima, Tokyo, Japan) at 80 kV with 
15,000X magnification. Images were acquired using a Hamamatsu Camera 
(Hamamatsu Photonics K.K., Japan) and Advanced Microscopy Techniques Camera 
System software version 534.4 (Woburn, Massachusetts, USA). Images were formed 
into composites and cropped in Adobe Photoshop CS4 (Adobe).  
 
2.7.1 Image Quantification  
To quantify morphological changes in OHCs and PCs, transverse sections from 
three animals for each condition were analyzed with ImageJ (Rasband, 1997) analysis 
software. To quantify the presence of microtubules, a horizontal line was drawn at 
distances 2, 4, and 6 μm from the lumenal surface of PCs and the number of 
intersecting microtubules was counted. The cuticular plate thickness was measured as 
the average vertical distance from the lumenal membrane of the second row OHC 
through the dense-actin meshwork at the lumenal OHC cytoplasm at three locations 
below the center of the three stereocilia rows. This measurement was repeated for three 
samples for each condition and compared using the sample mean and pooled standard 
deviation. To calculate the average inner hair cell-to-outer hair cell (ITO) distance as 
previously described (Jacques et al., 2007), the horizontal distance from the lateral side 
of the IHC to medial side of the first OHC was measured in 2 basal and 2 apical 
samples from 2 animals for each condition at 1 µm, 3 µm, and 5 µm distances from the 
lumenal surface of the PC. To quantify the morphology of OHCs, measurements of 
OHC length and width were also made. For all measurements, the mean, standard 
deviation, and standard error of the mean were calculated for each condition. Analysis 
of statistical significance was determined using student’s T-test. 
 
2.8 IMMUNOHISTOCHEMISTRY 
2.8.1 Performed on Sectioned Tissues  
Samples were fixed in 4% paraformaldehyde for 4 hours, rinsed, passed through 
an increasing sucrose gradient from 5-30%, embedded in OCT (Sakura, New York, 
USA) and cryosectioned at 12 μm thickness. Sections were permeabilized with 0.2% 
Tween-20 in 1X PBS, followed by blocking with 10% normal horse serum and 
incubated overnight in primary antibody (acetylated tubulin, Sigma, 1:750; p75ntr, 
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Covance, 1:1000; ZO-1, Millipore, 1:1000; S100-A1, Neomarkers, Kalamazoo, 
Michigan, USA, 1:500; CD44, BD Pharmigen, Franklin Lakes, New Jersey, USA, 
1:200; p-Cofilin, Santa Cruz Biotechnology, Santa Cruz, California, USA, 1:500 ) at 
4°C. Primary antibodies were detected using either Alexa Fluor 488 or 546 (Invitrogen, 
1:1000) conjugated secondary antibodies. Directly conjugated Phalloidin 633 
(Invitrogen, 1:5000) was applied to all samples. To localize prosensory markers in 
embryonic stages of development, tissues were prepared as mentioned but fixed 
overnight at 4C and the following antibodies were applied: anti-Sox2 (Santa Cruz 
Biotechnologies, 1:250), anti-Myosin 6 (Proteus, 1:1000), anti-β-tubulin III (TuJ1) 
(Sigma-Aldrich, 1:250), anti-Jagged1 (Santa Cruz Biotechnologies, 1:250), anti-Prox1 
(Covance, 1:400), anti-p75ntr (Millipore, 1:500), anti- p27Kip1 (Neomarkers, 1:300), 
anti-Islet1 (Abcam, 1:250), anti-Atoh1 (Driver et al., In press). Primary antibody 
labeling was detected by incubation for one hour at room temperature using Alexa 546, 
488, or 633-conjugated secondary antibodies (Invitrogen, 1:1000). Filamentous actin 
was detected using fluorophore-conjugated Phalloidin (Invitrogen, 1:200). 
 
2.8.2 Performed on Whole-Mount Tissues  
Cochleae prepared for whole mount immunohistochemistry differed in that 
samples were fixed for 2 hours at 4C and were labeled with a primary antibody 
(acetylated tubulin, Sigma, 1:750; p75ntr, Covance, Princeton, New Jersey, USA, 1:750; 
ZO-1, Millipore, 1:1000; β-tubulin I&II, Sigma, 1:750; S100-A1, Neomarkers, 
Kalamazoo, Michigan, USA, 1:1000). Directly conjugated Phalloidin 633 (Invitrogen, 
1:5000) was applied to all samples. Samples were mounted in Fluoromount-G 
(Southern Biotech) beneath No. 1½ glass coverslips (Corning, New York, USA) 
adhered with nail polish.  
 
2.8.3 Image Acquisition, Processing, and Quantification 
All fluorescence images were acquired at room temperature with LSM 510 
acquisition software as 12 µm Z-stacks with 1 µm optical sectioning using a Zeiss 510 
LSM Confocal Microscope with 40X oil objective (NA 1.3, WD= 0.21 mm, ∞ 0.17, 
Plan-Neofluar, Zeiss). Using line scan analysis, fluorescence intensity was measured 
from projected Z-stacks with ImageJ (Rasband, 1997) analysis software in 2 µm areas 
at the lumenal surfaces of both PCs and OHCs, as this region was previously observed 
with Transmission Electron Microscopy to maintain a homogeneous cell cytoplasm 
from E16 through P5. To measure relative fluorescence intensity in whole-mount 
samples, a 20 µm3 average intensity z-projection was reconstructed using ImageJ 
analysis software (Rasband, 1997). Average gray values (mean±s.e.m. arbitrary units, 
AU) were calculated from 36 cells repeated for six animals.  Average fluorescence 
intensity (mean±s.e.m. A.U.) was calculated from 6 samples, and compared using 
student’s T-test. To quantify the difference in microtubules within OHCs, OHCs were 
first identified by row as containing stereocilia, and then were counted as positive or 
negative for β-Tubulin I&II fluorescence, as untreated OHCs contained β-Tubulin I&II 
at all time-points measured. Then the percent of positively labeled OHCs per culture 
(mean±s.e.m.) was calculated and compared between control and Fgf2- or SU5402-
treated conditions. To quantify the overlap between prosensory markers, phalloidin 
labeling was used to identify the overall width of the cochlear duct. Cross-sections 
(base or apex) also labeled with prosensory markers were quantified as a percentage of 
width relative to overall width. Measurements were repeated on 7-10 sections of a 
given region (base or apex) to generate normalized expression profile histograms for 
each prosensory marker. 
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3 RESULTS 
 
3.1 PAPER I 
As mentioned in the Introduction, previous research has suggested a cellular basis 
for the observed radial gradient in basilar membrane stiffness (Emadi et al., 2004). The 
aim of Paper I was to determine if differences in cell mechanical properties arise 
during cochlear development. Therefore, we adapted cochlear explant cultures for 
atomic force microscopy to measure the Ym of OHCs and PCs during development. 
We found that at Embryonic day E16, OHCs and PCs have similar cell surface 
mechanical properties both at the basal and apical regions of the cochlea. However, by 
P0, we found distinct distributions of OHC and PC stiffness. Finally, by P5, we 
observed increasing stiffness in PCs from basal to apical regions of the cochlea. This 
suggested that cytoskeletal components, mainly actin filaments and microtubules, are 
developing within the cell cytoplasm and contributing to the mechanical properties of 
these cells. To test this hypothesis, we applied pharmacological treatment with either 
Latrunculin A or Jasplakinolide to disrupt the dynamics of the actin cytoskeleton. 
Treatment with Latrunculin A destabilized actin filaments and significantly decreased 
Ym of OHCs but not PCs. Treatment with Jasplakinolide stabilized actin filaments and 
significantly increased Ym of both OHCs and PCs. Interestingly, disruption of Myosin 
II function with Blebbistatin treatment at P0 significantly softened OHCs but 
significantly stiffened PCs. Taken together, these data suggest that actin directly 
impacts OHC surface mechanical properties and indirectly impacts PC stiffness. 
 
As reported in Paper I, based on transmission electron microscopy studies, PCs 
at postnatal stages develop bundled arrays of microtubules that occupy the majority of 
the cytoplasm in adult tissues (Souter et al., 1998). To test the impact of microtubule 
development on cell surface mechanical properties, we treated cochlear explant cultures 
with either Nocodazole or Taxol. Treatment with Nocodazole depolymerized 
microtubules and significantly decreased Ym of OHCs but not PCs at P0. However, by 
P5, Nocodazole significantly decreased Ym of PCs but not OHCs. Treatment with 
Taxol disrupted microtubules and significantly decreased Ym of PCs but not OHCs at 
postnatal days 3 and 5. These data suggest that PC surface mechanical properties 
develop sensitivity to microtubules within the first postnatal week. It has been shown 
that other supporting cell types, such as Deiters’ cells that interdigitate between OHCs, 
also contain microtubules (Slepecky, 1996). Therefore, we performed line-scan 
analysis of Ym to examine the cell mechanical properties throughout the second OHC 
row. We found heterogeneity in Ym along the longitudinal axis of the cochlea, and we 
proposed that this is due to the cellular heterogeneity of hair cells and supporting cells. 
Furthermore, this phenomenon is sensitive to microtubule disruption as treatment with 
Nocodazole was shown to decrease surface stiffness heterogeneity at P3. 
 
Finally, we proposed that the Fibroblast growth factor (Fgf) signaling pathway 
modulates the time course of developing cell surface mechanical properties in the 
cochlea. Using fluorescence immunohistochemistry, we found that cochlear explant 
cultures treated with Fgf2, which stimulates all Fgf receptors, significantly decreased 
OHC and PC filamentous actin, while treatment with SU5402, which inhibits all Fgf 
receptors, significantly increased OHC filamentous actin. This disruption of actin in 
Fgf2 treated cultures may explain in part the observed softening of OHCs and PCs. To 
begin to understand the downstream mechanism underlying the functional changes with 
Fgf2 treatment, cochlear explant cultures were treated with Fgf2 and one of the 
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following: Rho-associated kinase inhibitor Y27632, mitogen-activated 
threonine\tyrosine kinase (MEK) inhibitor U0126, or c-Jun N-terminal kinase inhibitor 
SP60012. Only treatment combining Fgf2 with Y27632 significantly increased both 
OHC and PC surface stiffness at P3 when compared to cultures treated with Fgf2 alone. 
Treatments combining Fgf2 with either U0126 or SP60012 also increased PC stiffness 
when compared to cultures treated with Fgf2 alone, but this difference was not 
statistically significant.  
 
3.2 PAPER II 
To understand which Fgf-receptor(s) may contribute to the changes in cell surface 
mechanical properties observed in Paper I, we took advantage of an in vivo mouse 
model deficient in Fgf-receptor 3 (Fgfr3) (Colvin et al., 1996; Hayashi et al., 2007; 
Puligilla et al., 2007). The aim of Paper II was to determine if this receptor disrupts 
cell mechanics and if so then to outline the mechanism by which Fgf-receptor 3 might 
disrupt the cytoskeleton of the affected cell type(s). Previously, it was reported that 
Fgfr3-/- mice have a 60 dB sound pressure level hearing loss (Colvin et al., 1996) and 
lack otoacoustic emissions (Puligilla et al., 2007). Therefore, we first wanted to 
examine OHC electromotility, as changes in electromotility may confound 
interpretation of any changes to OHC surface mechanical properties. Isolated OHCs 
were tested for changes in voltage-independent (linear) and voltage-dependent (non-
linear) capacitance, as well as electrical charge transfer, and the membrane potential at 
the observed peak in capacitance. All parameters tested did not present a statistically 
significant difference between OHCs from Fgfr3+/- and Fgfr3-/- mice. This suggested 
that Fgfr3 does not change the development of motor and sensory functions of OHCs. 
 
One possible cause of the deafness observed in mice and humans with mutations 
in Fgfr3 (Puligilla et al., 2007; Doherty et al., 2007) is the disruptions to supporting cell 
stiffness. Therefore, we examined the cell surface mechanical properties of OHCs and 
PCs in cochlear explant cultures from Fgfr3+/- and Fgfr3-/- mice. We found that both 
OHC and PC stiffness is significantly reduced in Fgfr3-/- relative to Fgfr3+/- conditions. 
The decreased PC stiffness was not surprising given the observed malformations in 
organization of the sensory epithelium, decreased microtubule formation and decreased 
inner hair cell-to-outer hair cell (ITO) distance. However, the decreased OHC stiffness 
was not expected given that these cells seemed to have apparently normal morphology 
and function. It is possible that the OHC cytoskeleton, or the OHC tight junctions 
between Deiters’ cells that anchor cytoskeletal components, may be disrupted due to 
the patterning defects previously described in this tissue (Hayashi et al., 2007; Puligilla 
et al., 2007). 
 
The observed impact of microtubule disruption on cell surface mechanical 
properties in Fgfr3-deficient mice led to the hypothesis that Fgf-signaling might 
regulate microtubule formation during cochlear development. To begin to understand 
the regulation by Fgf-signaling at the transcriptional level, RNA was isolated from 
cochlear explant cultures that had been treated with either Fgf2 or SU5402. A gene 
expression profile of 84 cytoskeletal regulators was generated with quantitative real-
time PCR for each condition and compared to vehicle control. Five genes were found to 
be significantly up-regulated in Fgf2- or SU5402-treated conditions, which included 
three microtubule regulators. Mapre2 showed a three-fold increase in gene expression 
in SU5402-treated conditions, Mark2 showed a four-fold increase in gene expression in 
SU5402-treated conditions, and Clasp2 showed a three-fold increase in gene expression 
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in Fgf2-treated conditions. Together, these data suggest that Fgf-signaling indirectly 
impacts microtubule formation by altering transcription of microtubule regulators.  
 
3.3 PAPER III 
Previous work has shown that the thyroid hormone signaling pathway has several 
points of interaction with Fgf-signaling (for review see Williams et al., 2007) and 
previously it was reported that thyroid hormone receptors transcriptionally regulate 
Fgf-receptor 1(Fgfr1) in developing osteoblasts (O’Shea et al., 2007). The aim of 
Paper III was to examine if thyroid hormone levels regulate Fgf-signaling during 
cochlear development. Therefore, we developed a treatment protocol to render mice 
hypothyroid in vivo at embryonic and postnatal stages of development. We found 
increased mRNA expression of Fgfr1 and Fgfr3 in hypothyroid cochleae relative to 
control conditions. Using in situ hybridization, we localized the increase in Fgfr1 to 
supporting cells of the greater epithelial ridge. We also observed a delayed down-
regulation of Fgfr3 in OHCs. This suggested that the phenotypic developmental delay 
seen in cases of hypothyroidism may contribute to cell shape and cell structural 
changes in the cochlea. 
 
To characterize this developmental delay at the cellular level, we examined the 
protein localization of PC markers with immunohistochemistry in control and 
hypothyroid cochleae. We found that onset of calcium binding protein S100-A1 at E16, 
and down-regulation of neurotrophin receptor p75 (p75ntr) at P3 were delayed in 
hypothyroid cochleae relative to control conditions. Furthermore, a decrease in CD44 
expression, a marker of differentiated PCs, was observed in hypothyroid cochleae at 
P6. To examine the impact of delayed differentiation on the cytoskeleton, we used 
transmission electron microscopy to compare actin filament and microtubule formation 
in hypothyroid and control cochleae. We found fewer microtubules in hypothyroid 
cochleae, and found defects in OHC morphology. To quantify this difference in OHCs, 
we calculated the cell width-length ratio and compared between hypothyroid and 
control conditions. We found a significantly increased width-length ratio in 
hypothyroid OHCs when compared to control conditions. Using 
immunohistochemistry, we observed a reduction in acetylated tubulin in hypothyroid 
supporting cells. These experiments showed that thyroid hormone levels contributed to 
the developing cytoskeleton of OHCs and PCs, and therefore may also disrupt cell 
mechanical properties. 
 
To test the functional consequences of hypothyroidism, cochlear explant cultures 
at embryonic and postnatal stages were established for atomic force microscopy. We 
found that PC stiffness was significantly decreased at P5, which was expected given the 
significant reduction in microtubules. However, hypothyroid PCs were significantly 
stiffer when compared to control conditions at E16 and P0. In addition, hypothyroid 
OHCs showed a trend from E16 to P0 towards increased cell stiffness that was 
statistically significant relative to control conditions at P3. Together, these data raised 
the possibility that actin may also contribute to developing cell mechanical properties. 
Therefore, we treated hypothyroid cochlear explant cultures with Latrunculin A and 
proposed that disruptions to actin formation would decrease Ym. Indeed, both 
hypothyroid OHCs and PCs were significantly softer after treatment with Latrunculin 
A, supporting the consensus that uncontrolled actin formation was responsible in part 
for the aberrant increase in developing cell mechanical properties in hypothyroid 
conditions. 
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Finally, we explored the mechanism by which thyroid hormone induced actin-
based stiffening in OHCs and PCs. As a first step, we profiled a panel of 84 
cytoskeleton regulators for gene expression changes in hypothyroid conditions using 
quantitative real-time PCR. Since there were no statistically significant differences in 
cytoskeletal regulators between hypothyroid and control conditions, we examined 
potential signaling cascades downstream of the Fgf-signaling pathway. First, we 
identified increased phosphorylation of Fgf-receptors at E16 that persisted at P0. As 
mentioned in the Introduction, Fgf-receptors are members of a family of tyrosine 
kinase receptors that have been shown to act through four key signaling cascades, 
which include mitogen-activated kinase (MAPK), phosphoinositide 3-kinase (PI3K), 
signal transducer and activator of transcription (STAT), and phospholipase C-gamma 
(PLC-γ). We found that Lim-kinase (LIMK), an intermediary in the MAPK signaling 
cascade (Edwards et al., 1999) showed increased phosphorylation in hypothyroid 
relative to control conditions.  LIMK has been shown to interact with key regulators of 
actin dynamics, including, but not limited to, cofilin. Phosphorylation of actin-
depolymerizing factor cofilin was also significantly decreased in hypothyroid relative 
to control conditions. Decreased phosphorylation of cofilin has been shown to lead to 
an increase in actin filament formation (Marsick et al., 2010) by creating free barbed 
ends for polymerization, which may explain in part the stiffening of hypothyroid OHCs 
and PCs. In order to localize this difference in cofilin phosphorylation, we applied 
immunohistochemistry to cross-sectioned cochleae from hypothyroid and control 
conditions, using a commercially available antibody raised against phosphorylated 
cofilin. We found decreased phosphorylated cofilin in the nucleus of hypothyroid 
OHCs relative to controls. Taken together, these data suggest that altered cofilin 
activity may play a role in the increased actin-based stiffness in hypothyroid conditions.  
 
3.4 PAPER IV 
Specification of a population of prosensory cells with the ability to develop as 
hair cells or supporting cells is a key step in the development of the sensory epithelium.  
But the factors that specify this population of cells are only beginning to be understood. 
Here, we examined the expression of putative prosensory markers in the developing 
mouse cochlea. By E14.5 three prosensory markers were visible at mid-basal sections, 
Sox2, Jagged1, and Islet1. However, these markers had very little overlap when 
confocal images were examined in pseudo-overlay. The Sox2 immunopositive region 
was the most narrow and medially localized. The Jagged1 immunopositive region 
extends most laterally. By E13.5, Jagged1 expression had narrowed somewhat. At time 
points examined between E12.5 and E14.5, Islet1 expression was the broadest, 
overlapping with the Sox2-positive region and extending through the lateral epithelial 
ridge. Even at E14.5, Islet1 expression extends more laterally than either Sox2 or 
Jagged1. Interestingly, along this same time course, spiral ganglion fibers also 
developed along the cochlear duct, as detected by neuronal-specific β-tubulin III, 
before hair cell formation began. These results demonstrate that while Sox2 and 
Jagged1 are required for prosensory formation, they are not definitive markers of this 
domain, suggesting that other factors probably act to refine the prosensory domain 
beyond the expression of Sox2, Jagged1, and Islet1. 
 
Beginning between E13.5 and E14.5, a subset of cells within the Sox2, Jagged1, 
and Islet1 domain become positive for the cell-cycle inhibitor, p27Kip1.   While not 
required for prosensory formation (Chen and Segil, 1999), expression of p27Kip1 
appears to be the most definitive marker for the prosensory domain. Expression of 
p27Kip1 identifies the prosensory cells that have become post-mitotic from the non-
   25 
sensory regions of Kölliker’s organ and the lateral epithelial ridge. By E14.5, 
supporting cell markers Prox1, a prospero-related homeodomain transcription factor, 
and neurotrophin receptor p75 (p75ntr) were apparent at mid-basal regions of the 
cochlear duct and overlapped with the early prosensory markers Sox2, Jagged1, and 
Islet1. Both p75ntr and Prox1 are expressed in just the lateral two-thirds of the 
prosensory domain with a sharp medial border.  Preliminary profiling of expression for 
Prox1 of p75ntr with the hair cell marker Atoh1 indicates that a majority of hair cells 
may arise from the approximately one-third of the prosensory domain that is negative 
for p75ntr and Prox1, but further analysis is required to confirm this possibility. By E15, 
overlap between Jagged1 and Sox2 had increased. Of particular interest, the overlap 
between Jagged1 and β-tubulin III may indicate the presumptive prosensory region 
along the cochlear duct. 
 
Between E16 and P0, strong distinctions in marker expression become evident in 
sensory hair cells and non-sensory supporting cells. Beginning at E16, 
immunohistochemistry of cochlear cross-sections showed that p75ntr expression is 
down-regulated in most cells within the prosensory domain with the exception of 
developing pillar cells. Pillar cells, as well as most other supporting cells, also 
expressed both Sox2 and Jagged1. However, Jagged1 expression was down-regulated 
in the most lateral region of the organ of Corti. As expected, there was no overlap 
between Numb, an antagonist of Notch signaling, and Jagged1. It was interesting to 
note that while all Jagged1-positive cells were also Sox2-positive, not all Sox2-positive 
cells contained Jagged1. In contrast to the supporting cells, OHC expression of both 
Sox2 and Jagged1 was completely lost in Myosin 6-positive hair cells. Finally, Islet1 
expression, maintained throughout embryonic development including P0, was similar 
to p75ntr. There was an overlap observed between Islet1 and both Jagged1 and Sox2 
expression profiles. 
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4 DISCUSSION AND FUTURE DIRECTIONS 
 
4.1 PAPER I 
With the adaptation of cochlear explant cultures to atomic force microscopy, we 
can quantify the material properties that resist deformation at the cellular level. This 
resolution was shown by our measurements of stiffness heterogeneity along OHC rows, 
which indicated that areas at cell-cell junctions have a higher Young’s modulus (Ym) 
than the center of the cell. Furthermore, supporting Deiters’ cells, which interdigitate 
between OHCs and are composed of primarily microtubules, showed a higher 
resistance to deformation when compared to OHCs in the same row at postnatal stages. 
This is a strong advantage of our technique as future experiments could assess the 
impact of developing tight and adherens junctions on hair cell and supporting cell 
stiffness. Furthermore, cell junctions often provide stability points to connect actin and 
microtubule networks, and could be explored in more detail to understand the 
relationship between these cytoskeletal components in dictating the heterogeneity of 
cell surface mechanical properties. 
 
This high resolution of our technique has also limited the extent to which AFM 
can probe the dense cytoskeletal network deep within the OHC cytoplasm. The 
indentation depth for this technique measured 1.5 µm, which may limit the extent to 
which our measurements of Ym represented the stiffness of the entire OHC. This depth 
was critical to minimize the impact of cell membrane mechanics on measurements of 
cell stiffness (Sen et al., 2005) and it was clear from transmission electron micrographs 
that this indentation depth remained homogeneous throughout the developmental time 
course under consideration. It would be interesting to compare these measurements of 
individual cell stiffness to the mechanics of the reticular lamina that forms after P10 
(Leonova and Raphael, 1997) and forms a critical barrier between endolymph and 
perilymph fluids (Bohne and Rabbitt, 1983). This assessment of cell surface 
mechanical properties ought to be considered in context as a critical first step, and 
could well be applied to modeling and mechanics studies of the main events in 
morphogenesis, namely the cellular exertion of force during cellular protrusion and cell 
motility, and the cellular resistance to deformation during development.  
 
4.2 PAPER II 
This study reaffirms the utility of the Fgfr3-/- mouse as a model to study the 
impact of supporting cells on the mechanics of hearing. As OHC function appeared 
normal, new considerations should be raised to better understand the 60 dB sound 
pressure level hearing loss and lack of otoacoustic emissions. One possibility may be 
that a loss of endocochlear potential in these mice may be contributing to OHC function 
in vivo. However, a loss of endocochlear potential in these animals seems unlikely, 
given that previous cases of disruption to potassium recycling result in a degradation of 
OHCs (Okano and Iwai, 1975; Bohne and Rabbitt, 1983), which was not seen in Fgfr3-
/- mice (Colvin et al., 1996; Hayashi et al., 2007; Puligilla et al., 2007). Another more 
likely contribution comes from the underdeveloped supporting cells, which fail to form 
the fluid filled Spaces of Nuel (Souter et al., 1997) and inner and outer Tunnels of Corti 
(Scott, 1909; Lim and Anniko, 1985). The field of fluid flow in the cochlear duct is still 
largely unexplored, but stroboscopic image analyses have implicated fluid flow through 
the tunnel of Corti as contributing to hearing function (Karavitaki and Mountain, 2007). 
Furthermore, the fluid spaces of Nuel are thought to be a permissive requirement for 
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OHC amplification in vivo (Zagadou and Mountain, 2012). Together, this work 
supports the need for a better understanding of the process by which non-sensory 
supporting cells amplify or dampen sensory hair cell mechanotransduction. In this 
study, we identified five candidate genes (Clasp2, Crk, Cyfip1, Mapre2, Mark2) that 
may be responsible for supporting cell development and in particular for the 
morphological changes of supporting cells during postnatal stages of maturation. 
Interestingly, the majority of genes with significantly increased fold-change expression 
were directly or indirectly linked to microtubule formation (Mimori-Kiyosue et al., 
2005; Sapir et al., 2008; Vitre et al., 2008). Future experiments localizing these 
candidates to the sensory epithelium with in situ hybridization or 
immunohistochemistry, and interrogating these gene promoter and enhancer regions for 
putative regulatory sequences, would further establish the role for Fgf-signaling on 
microtubule formation.  
 
In this thesis, measurements of the material properties of supporting cells were 
limited to supporting PCs and the surface of Deiters’ cell processes in OHC row 2. 
However, the cochlear sensory epithelium after the onset of hearing contains 7 
morphologically distinct subtypes of supporting cells, including border cells, 
phalangeal cells, inner and outer PCs, Deiters’ cells, Hensen’s cells and Claudius cells 
(Lim and Anniko, 1985; Slepecky et al., 1996). Current distinctions between these 
subtypes include the location of the supporting cell nucleus relative to the basilar 
membrane, and the positional identity of each cell within the sensory epithelium. 
Additional research characterizing supporting cell subtypes of developing epithelia 
would complement established morphological distinctions, and permit additional 
measurements of these cell surface mechanical properties in vitro.  In Paper II, close 
examination of transmission electron micrographs in Fgfr3+/- and Fgfr3-/- cochleae led 
to the conclusion that both inner and outer PCs, as well as an inner phalangeal cell, 
were present in both genotypes. This was based primarily on the location of the cell 
type within the epithelium, as well as the position of the nucleus relative to the basilar 
membrane. Other interpretations could be that overproliferating phalangeal cells, or 
movements of non-sensory cells from Kölliker’s organ, are recruited to maintain the 
interdigitation of hair cells and supporting cells characteristic of the auditory organ. 
Before a thorough characterization of this mouse model can be completed, new and 
unique supporting cell markers are necessary to identify sub-populations of supporting 
cells. One clue may be in candidates with some impact on nuclear positioning (Miller et 
al., 1998) or cell adhesion properties that mediate intercellular recognition signaling 
cascades (Simonneau et al., 2003). 
 
4.3 PAPER III 
As mentioned briefly in the Introduction, there are many distinct points of cross-
talk between thyroid hormone signaling and fibroblast growth factor signaling 
pathways. The most direct regulation of thyroid hormone receptors occurs when these 
receptors bind transcriptional regulatory sequences in either promoter or enhancer 
regions that control target gene transcription (Weitzel, 2008). Previously, it was shown 
that treatment with thyroid hormones induced Fgfr3 and Fgfr1 expression in osteoblast 
cells lines (Barnard et al., 2005); the development of new techniques that include 
single-cell reporter assays in cochlear explant cultures might someday lend insight into 
a direct mechanism. In addition, thyroid hormones also have been shown to bind 
integrin receptors αV and β3 (Bergh et al., 2005), which induce downstream activation 
of MAPK signaling cascades. This receptor-independent regulation is an appealing 
mode of spatially controlled cross-talk given that the cochlea undergoes dynamic 
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expression of several integrin receptors that are responsible, in part, for Fgf-mediated 
cell growth (Toyama et al., 2005). Thyroid hormone receptors can also remain in the 
cell cytoplasm independent of ligand and have been shown to bind the regulatory 
subunit of PI3K (Kenessey and Ojamaa, 2006), which contains an SH2 domain capable 
of binding phosphorylated tyrosine residues (Songyang et al., 1993) such as those 
found on Fgf-receptors. Finally, thyroid hormones may have indirect control over Fgf-
receptor activation by regulating the localization or bioavailability of heparin sulfate 
proteoglycans, as has been observed in developing bone tissue (Bassett et al., 2006). 
Overall, these several avenues of exploration would lead to further understanding of the 
cross-talk between these signaling pathways, and may provide additional biomarkers of 
thyroid hormone status in developing or developed tissues.  
 
One major goal for the developmental biologist in the field of hearing research is 
to translate the understanding of cochlear development for the regeneration or repair of 
damaged sensory epithelia. As the adult mammalian cochlea does not regenerate 
(Collado et al., 2011), much attention has been placed on mechanisms with the 
potential to repair or delay death of hair cells and supporting cells (Taleb et al., 2008; 
Hinz et al., 2011). Precise control over the timing of cellular differentiation, including 
the ability to de-differentiate adult tissues, could open new avenues for therapeutic 
intervention. In many ways, the developmental delay seen in hypothyroid conditions in
vivo is similar to the under-differentiation of developing cochlear explant cultures 
treated with Fgf2 in vitro. While still unexplored, it may be possible to force the 
differentiation of Fgf2 treated explants or Fgfr3-/- mice through the delivery of thyroid 
hormones. It would be very interesting to understand the extent to which these same 
mechanisms are active in adult or aging systems. Fgf2 treated explants in vitro lose the 
potential to de-differentiate by P5, yet it is still uncertain if Fgf signaling persists as 
there is evidence for a persistent expression of Fgf-receptors in the cochlea (Pirvola et 
al., 1995). Even if these mechanisms are not readily accessible in the aging cochlea, 
future progress into genetic and epigenetic methods may shed new light on how best to 
harness the key growth factors from development to extend the hearing function of the 
aging cochlea. 
 
4.4 PAPER IV 
The identification of a homogenous measurement of Ym in the cochlear sensory 
epithelium at E16 in Paper I suggests that the prosensory region has not yet 
differentiated to distinguish hair cell from support cell stiffness. In Paper IV we have 
been able to refine the definition of the presumptive organ of Corti using multiple 
markers of the prosensory domain, such as Jagged1 and Sox2. This systematic 
investigation raises new possibilities for investigators interested in applying the 
cochlear epithelium to modernized single-cell analyses, which would require a high-
throughput enrichment of clonal cell populations. Furthermore, it would be interesting 
to examine the stiffness differences between the prosensory region of the cochlear duct 
and other non-sensory regions as early as E13. Recent work identifying new cell-
surface receptors in the prosensory domain suggests that the cell membranes of 
prosensory and nonsensory cells may have different material properties. To examine 
the cell membrane with an AFM, additional experiments to optimize the efficiency of 
force-imaging are essential. Currently, topography of epithelial cells can be examined 
with a commercial AFM in tapping mode, but image acquisition takes minutes. This 
long time scale leads to either a sacrifice of high spatial resolution of AFM, or a 
degradation of the tissue if multiple images are acquired on the same tissue. 
Advancements in ion-conductance scanning AFM (Novak et al., 2009) have taken the 
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first step to minimizing the disadvantage of low spatial resolution, and may be able to 
quantify the density of cell surface receptors that show differential expression in 
prosensory and nonsensory regions of the cochlear duct. 
 
There is growing evidence that mechanical cues may direct differentiation in 
resident stem cell populations of several human and mouse tissues (Engler et al., 2006). 
But the impact of substrate stiffness on prosensory cell specification has not yet been 
tested. The expression of p75ntr in a subset of supporting cells, namely the PCs, is a 
marker of a less-differentiated state in the cochlea (Jacques et al., 2007) and suggests 
that these cells may have a yet underappreciated plasticity that remains after cell fate 
specification. Indeed, expression of p75ntr in Schwann cells (Soilu-Hänninen et al., 
1999) has been observed in cases of neuron damage and proliferation (King et al., 
2000). While it may be possible to extend expression of this neurotrophin receptor by 
altering the time course of exposure to growth factors or thyroid hormones, it remains 
to be seen how expression of p75ntr alters the expression of cell cycle controls or 
correlates with proliferation in the cochlea. Additional experiments aimed at altering 
the mechanical properties of the basilar membrane substrate beneath this sensory 
epithelium may work in concert with differentiation factors such as p75ntr to control the 
proliferation of single-cell populations. Alternatively, with the introduction of hair cell-
like stem cells (Oshima et al., 2010) and cochlear progenitor cell lines (Kwan et al., in 
preparation) the substrate matrix elasticity could be experimentally altered to determine 
which substrate stiffness promotes, permits, or inhibits expression of p75ntr. Both lines 
of research could lend insight into the pathways of differentiation that could be applied 
towards regrowth or repair of the cochlear sensory epithelium. 
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7 APPENDIX I 
 
For each force-distance curve, Young’s modulus was estimated with a non-linear 
least-squared fit to Sneddon’s model for an indenting cone (Sneddon, 1965): 
 
 
where F is the applied force, δ is the indentation, α is the half-angle of the cone and 
assumed to be 35, and Poisson’s ratio (υ) is assumed to be 0.5. Force is expressed in 
terms of cantilever deflection (d) and cantilever spring constant (k) as: 
 
The indentation, δ, is calculated as: 
 
 
where Z is the distance of the piezo displacement of the cantilever and Z0 is the piezo 
distance at the contact point.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
